Overview 

Heart enlargement, or cardiomegaly, is a condition where the heart becomes larger than normal, often due to an underlying cardiovascular disease such as coronary artery disease, valvular heart disease, or cardiomyopathies. Surgical interventions aim to alleviate symptoms, improve cardiac function, and enhance the quality of life for individuals affected by the condition. This article provides a comprehensive review of the different surgical approaches, their effectiveness, and the evidence supporting their use.

What is cardiomegaly?

Cardiomegaly is a medical condition in which the heart becomes enlarged beyond its normal size. This enlargement results from structural or functional changes in the heart, often due to underlying conditions such as high blood pressure, coronary artery disease, valvular disorders, or cardiomyopathies. While cardiomegaly itself is not a disease, it is a significant indicator of potential heart dysfunction. This is because an enlarged heart may struggle to pump blood efficiently, leading to symptoms such as shortness of breath, fatigue, and fluid retention. Early diagnosis and management of the underlying cause are crucial for preventing complications and improving overall cardiac health.

Why is surgery needed?

While medications such as ACE inhibitors, beta-blockers, and diuretics remain the first line of treatment, not all patients achieve adequate symptom control with drugs alone.⁴ In progressive cases, surgery is considered to:

• Restore blood flow (revascularisation)
• Reshape or support weakened chambers 
• Correct valve dysfunction 
• Provide mechanical circulatory support 
• Replace the heart entirely when other measures fail
  

The decision to move toward surgery is based on careful risk-benefit analysis. Surgeons and cardiologists evaluate not only the severity of enlargement but also comorbidities, patient age, functional capacity, and the likelihood of improved quality of life after intervention. In some cases, surgery is life-saving; in others, it is considered palliative, aimed at reducing symptoms rather than extending life.

Different surgical approaches 

Surgical treatments for cardiomegaly focus on addressing the underlying cause and improving heart function. The choice of surgery depends on the patient’s condition, symptoms, and overall health. Below is an overview of the main surgical approaches used to manage cardiomegaly.

Coronary Artery Bypass Grafting (CABG)

Overview:

CABG is one of the most common heart surgeries. It’s used when the arteries that supply blood to the heart (coronary arteries) are blocked, which can cause heart enlargement and heart failure. In a CABG operation, surgeons take a healthy blood vessel from another part of the body (like the leg or chest) and “bypass” the blockage, making a new route for blood to reach the heart muscle.

Effectiveness:

Studies have shown that CABG can improve heart pumping strength and reduce symptoms such as chest pain and shortness of breath. For instance, a study by Velazqueuz et al. (2011) demonstrated that CABG improved survival and reduced hospitalisations in patients.¹

Considerations:

While effective, CABG may not be suitable for all patients, especially those with significant permanent heart muscle damage or other serious health issues. CABG remains particularly beneficial for patients with viable myocardium, meaning the heart muscle can still recover once blood flow is restored. However, in cases of extensive scarring or infarction, the survival advantage is less pronounced.

Surgical Ventricular Restoration (SVR)

Overview:

When part of the heart muscle is badly damaged after a heart attack, the left ventricle (the heart’s main pumping chamber) can become enlarged and weak. SVR is a procedure to reshape the heart back into a more normal, oval shape.

Effectiveness:

A large study, known as the STICH trial, found that adding SVR to CABG did not significantly improve survival rates compared to CABG alone.⁵ However, some patients experienced symptomatic relief and improved quality of life.

Considerations:

SVR is typically considered for patients with very large damaged areas (especially in the front wall of the heart) and severe loss of pumping function. Although SVR is less common today, it still has a role in carefully selected patients. Improved patient selection, better surgical techniques, and integration with other procedures may enhance outcomes in the future.

Mitral valve surgery 

Overview:

The mitral valve helps control blood flow between the left atrium and left ventricle. In some patients, when the heart is enlarged, the valve does not close properly, causing blood to leak backward (called mitral regurgitation). This makes the heart work harder. Mitral valve surgery involves repairing or replacing this valve.

Effectiveness:

A study by Andalib et al. (2016) indicated that mitral valve repair in such patients led to improved survival and reduced heart failure symptoms.² However, the benefits may vary depending on the severity of the regurgitation and the patient’s overall condition.

Considerations:

The timing of surgery is crucial; early intervention before the onset of irreversible myocardial damage yields better outcomes. Valve repair is generally preferred over valve replacement because it preserves native structures and has lower long-term complications. However, replacement is necessary when damage is too severe. Advances in minimally invasive and transcatheter valve procedures are also expanding options for high-risk patients.

Left Ventricular Assist Devices (LVADs)

Overview: 

An LVAD is a mechanical pump that is implanted to help the weakened left ventricle pump blood around the body. It is often used as a “bridge” for patients waiting for a heart transplant, or sometimes as a long-term therapy if a transplant is not possible.

Effectiveness: 

Research by Slaughter et al. (2009) demonstrated that LVADs significantly improved survival and quality of life in patients with end-stage heart failure.³ In recent years, “destination therapy” with LVADs, where the device is implanted permanently rather than as a bridge to transplant, has become more common. This has extended survival in patients who otherwise had no treatment options, although it requires lifelong device management. 

Considerations:

Although lifesaving, LVADs are associated with risks such as infection, bleeding, and thrombosis (blood clots). Patients also need to carry a battery pack outside the body to keep the pump running. They are typically considered when other surgical options are not viable.

Heart transplantation 

Overview:

For patients with end-stage heart failure, where the heart is too weak to be helped by other surgeries, a heart transplant is often the only option. The damaged heart is removed and replaced with a healthy donor heart.

Effectiveness:

Heart transplants can be life-transforming. Many patients go on to live for years with greatly improved energy, reduced symptoms, and better overall quality of life. Survival rates after transplant have improved significantly in recent decades.

Considerations:

The main challenges are the shortage of donor hearts, the need for lifelong medications to prevent the body from rejecting the new heart, and risks linked to weakened immunity. Post-transplant survival averages 10-15 years, but many patients exceed this with careful follow-up. Advances in immunosuppressive therapy and donor-recipient matching have dramatically improved long-term outcomes. However, donor scarcity remains the greatest limiting factor.

Comparative effectiveness 

This comparison highlights that while CABG and mitral valve surgery offer benefits in selected populations, LVADs and heart transplantation provide the most dramatic improvements for patients with advanced disease. Ultimately, the choice of surgery depends on patient-specific characteristics, the reversibility of damage, and access to resources.

FAQs

What is the most common cause of heart enlargement?

The most common cause is coronary artery disease, leading to ischemic cardiomyopathy. 

Are there non-surgical treatments for heart enlargement?

Yes, medications such as ACE inhibitors, beta-blockers, and diuretics can help manage symptoms and prevent progression.

How do I know if I need surgery for heart enlargement?

Decisions are based on factors like the severity of symptoms, underlying cause, and overall heart function, often determined through imaging studies and clinical evaluation.

Can lifestyle changes help manage heart enlargement?

Yes, adopting a heart-healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking, can improve heart health and complement medical treatments.

Summary

The choice of surgical intervention for heart enlargement depends on the underlying cause, the patient’s overall health, and the specific characteristics of the cardiac enlargement. While CABG remains a cornerstone for ischemic heart disease, other interventions like SVR, mitral valve surgery, LVADS, and heart transplantation offer benefits in select patient populations. A multidisciplinary approach is crucial for determining the most suitable treatment for each individual.